Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Karl G. Braslis; Richard C. David; Eustos Nelson; Francisco Civantos; Mark S. Soloway

doi:10.1016/0090-4295(95)80028-X

Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Karl G. Braslis, Richard C. David, Eustos Nelson, Francisco Civantos, Mark S. Soloway

Research output: Contribution to journal › Article › peer-review

25 Scopus citations

Abstract

We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

Original language	English (US)
Pages (from-to)	329-331
Number of pages	3
Journal	Urology
Volume	45
Issue number	2
DOIs	https://doi.org/10.1016/0090-4295(95)80028-X
State	Published - Feb 1995

ASJC Scopus subject areas

Urology

Access to Document

10.1016/0090-4295(95)80028-X

Fingerprint Dive into the research topics of 'Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide'. Together they form a unique fingerprint.

Cite this

@article{89319100c9424e129d11e6146211bbd7,

title = "Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide",

abstract = "We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.",

author = "Braslis, {Karl G.} and David, {Richard C.} and Eustos Nelson and Francisco Civantos and Soloway, {Mark S.}",

year = "1995",

month = feb,

doi = "10.1016/0090-4295(95)80028-X",

language = "English (US)",

volume = "45",

pages = "329--331",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "2",

}

TY - JOUR

T1 - Squamous cell carcinoma of the prostate

T2 - a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

AU - Braslis, Karl G.

AU - David, Richard C.

AU - Nelson, Eustos

AU - Civantos, Francisco

AU - Soloway, Mark S.

PY - 1995/2

Y1 - 1995/2

N2 - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

AB - We report a primary squamous cell carcinoma of the prostate that developed in a 57-year-old man, 3 years after treatment with leuprolide and flutamide for Stage D1 adenocarcinoma of the prostate. This is the first case that describes this transformation from adenocarcinoma to squamous cell carcinoma following the use of luteinizing hormone agonists.

UR - http://www.scopus.com/inward/record.url?scp=0029245715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029245715&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(95)80028-X

DO - 10.1016/0090-4295(95)80028-X

M3 - Article

C2 - 7855985

AN - SCOPUS:0029245715

VL - 45

SP - 329

EP - 331

JO - Urology

JF - Urology

SN - 0090-4295

IS - 2

ER -

Squamous cell carcinoma of the prostate: a transformation from adenocarcinoma after the use of a luteinizing hormone-releasing hormone agonist and flutamide

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this